Deloitte expands Quartz AI™ Suite with Atlas AI™ for Drug Discovery

First-of-its kind Generative AI solution combines NVIDIA BioNeMo cloud APIs and training with Deloitte’s deep industry experience and skilled AI professionals to reimagine the drug discovery process Today, Deloitte announced Atlas AI™, the latest addition to its Quartz AI™ suite of cross-industry solutions built on the NVIDIA AI and NVIDIA Omniverse™ platforms. As the...

The post Deloitte expands Quartz AI™ Suite with Atlas AI™ for Drug Discovery first appeared on AI-TechPark.

ai ai solution apis atlas bionemo cloud deloitte discovery drug discovery experience generative industry kind nvidia nvidia ai nvidia bionemo process professionals quartz ai reimagine skilled solution solutions training